223 related articles for article (PubMed ID: 14594342)
1. A retrospective evaluation of vitamin K1 therapy to reverse the anticoagulant effect of warfarin.
Fan J; Armitstead JA; Adams AG; Davis GA
Pharmacotherapy; 2003 Oct; 23(10):1245-50. PubMed ID: 14594342
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of warfarin-induced hypoprothrombinemia with use of low-dose subcutaneous vitamin K1.
Fetrow CW; Overlock T; Leff L
J Clin Pharmacol; 1997 Aug; 37(8):751-7. PubMed ID: 9378848
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.
Tsu LV; Dienes JE; Dager WE
Ann Pharmacother; 2012 Dec; 46(12):1617-26. PubMed ID: 23249867
[TBL] [Abstract][Full Text] [Related]
4. Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation.
Nee R; Doppenschmidt D; Donovan DJ; Andrews TC
Am J Cardiol; 1999 Jan; 83(2):286-8, A6-7. PubMed ID: 10073841
[TBL] [Abstract][Full Text] [Related]
5. Randomized, placebo-controlled trial of orally administered vitamin K1 for warfarin-associated coagulopathy in Chinese patients with mechanical heart valves.
Zhang H; Li M; Ao XL; Dong YJ; Dong L
Eur J Clin Pharmacol; 2021 Sep; 77(9):1333-1339. PubMed ID: 33783553
[TBL] [Abstract][Full Text] [Related]
6. Oral vitamin K1: an option to reduce warfarin's activity.
Harrell CC; Kline SS
Ann Pharmacother; 1995 Dec; 29(12):1228-32. PubMed ID: 8672826
[TBL] [Abstract][Full Text] [Related]
7. Treatment of warfarin-associated coagulopathy: a physician survey.
Wilson SE; Douketis JD; Crowther MA
Chest; 2001 Dec; 120(6):1972-6. PubMed ID: 11742930
[TBL] [Abstract][Full Text] [Related]
8. An update of consensus guidelines for warfarin reversal.
Tran HA; Chunilal SD; Harper PL; Tran H; Wood EM; Gallus AS;
Med J Aust; 2013 Mar; 198(4):198-9. PubMed ID: 23451962
[TBL] [Abstract][Full Text] [Related]
9. Intravenous vitamin K1 injections: dangerous prophylaxis.
O'Reilly RA; Kearns P
Arch Intern Med; 1995 Oct; 155(19):2127-8. PubMed ID: 7575074
[No Abstract] [Full Text] [Related]
10. Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study.
Lubetsky A; Yonath H; Olchovsky D; Loebstein R; Halkin H; Ezra D
Arch Intern Med; 2003 Nov; 163(20):2469-73. PubMed ID: 14609783
[TBL] [Abstract][Full Text] [Related]
11. Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione.
Raj G; Kumar R; McKinney WP
Arch Intern Med; 1999 Dec 13-27; 159(22):2721-4. PubMed ID: 10597763
[TBL] [Abstract][Full Text] [Related]
12. Effective reversal of warfarin-induced excessive anticoagulation with low dose vitamin K1.
Shetty HG; Backhouse G; Bentley DP; Routledge PA
Thromb Haemost; 1992 Jan; 67(1):13-5. PubMed ID: 1615468
[TBL] [Abstract][Full Text] [Related]
13. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin.
Hylek EM; Regan S; Go AS; Hughes RA; Singer DE; Skates SJ
Ann Intern Med; 2001 Sep; 135(6):393-400. PubMed ID: 11560452
[TBL] [Abstract][Full Text] [Related]
14. Adherence to guidelines for the management of excessive warfarin anticoagulation.
Devine EB; Hopefl AW; Wittkowsky AK
J Thromb Thrombolysis; 2009 May; 27(4):379-84. PubMed ID: 18465088
[TBL] [Abstract][Full Text] [Related]
15. Impaired warfarin response secondary to high-dose vitamin K1 for rapid anticoagulation reversal: case series and literature review.
Fugate SE; Nichols CM; Cudd LA
Pharmacotherapy; 2004 Sep; 24(9):1213-20. PubMed ID: 15460182
[TBL] [Abstract][Full Text] [Related]
16. Reversal of overanticoagulation in very elderly hospitalized patients with an INR above 5.0: 24-hour INR response after vitamin K administration.
Pautas E; Peyron I; Bouhadiba S; Golmard JL; Gouronnec A; Oboa N; Siguret V; Gouin-Thibault I
Am J Med; 2011 Jun; 124(6):527-33. PubMed ID: 21605730
[TBL] [Abstract][Full Text] [Related]
17. The use of vitamin K in patients on anticoagulant therapy: a practical guide.
Hanslik T; Prinseau J
Am J Cardiovasc Drugs; 2004; 4(1):43-55. PubMed ID: 14967065
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of intravenous phytonadione (vitamin K1) in patients on long-term oral anticoagulant therapy.
Shields RC; McBane RD; Kuiper JD; Li H; Heit JA
Mayo Clin Proc; 2001 Mar; 76(3):260-6. PubMed ID: 11243272
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulant management of pregnant women with mechanical heart valve replacement during perioperative period.
Bian C; Qi X; Li L; Zhao J; Liu X
Arch Gynecol Obstet; 2016 Jan; 293(1):69-74. PubMed ID: 26048261
[TBL] [Abstract][Full Text] [Related]
20. Reversal of asymptomatic over-anticoagulation by orally administered vitamin K.
Baker P; Gleghorn A; Tripp T; Paddon K; Eagleton H; Keeling D
Br J Haematol; 2006 May; 133(3):331-6. PubMed ID: 16643436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
